Atlas Trials

A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension

Clinical trial NCT02929407 · TERMINATED

Trial details

NCT number
NCT02929407
Sponsor
Ferring Pharmaceuticals
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Portal Hypertension
Start date
2016-11-01
Primary completion
2017-09-27
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.